4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FDMT 4D Molecular Therapeutics

盘前交易 07-22 05:30:09 EDT

14.40

-0.74

-4.89%

最高15.24	最低14.15	成交量208.08万
今开15.24	昨收15.14	日振幅7.20%
总市值7.45亿	流通市值4.40亿	总股本5,170万
成交额3,025万	换手率6.81%	流通股本3,054万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FDMT","market":"US","secType":"STK","nameCN":"4D Molecular Therapeutics","latestPrice":14.4,"timestamp":1721419200000,"preClose":15.14,"halted":0,"volume":2080838,"delay":0,"floatShares":30543806,"shares":51703412,"eps":-2.416519,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.74,"latestTime":"07-22 05:30:09 EDT","open":15.24,"high":15.24,"low":14.15,"amount":30252949.939540002,"amplitude":0.071995,"askPrice":17.24,"askSize":100,"bidPrice":13.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.416519,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1607662800000,"adjPreClose":14.4,"postHourTrading":{"tag":"盘后","latestPrice":14.5,"preClose":14.4,"latestTime":"19:59 EDT","volume":8974,"amount":131083.4652,"timestamp":1721433542475},"volumeRatio":0.7899945868778863,"impliedVol":0.8052,"impliedVolPercentile":0.464},"requestUrl":"/m/hq/s/FDMT","defaultTab":"news","newsList":[{"id":"2452479222","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452479222","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452479222?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:39","pubTimestamp":1721396395,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日21时39分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下挫5.15%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Silo Pharma, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为867.01%、232.97%、128.99%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.、Altamira Therapeutics Ltd.，振幅分别为48.37%、23.44%、23.13%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719213955af93307e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719213955af93307e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2452482546","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅下跌5.00%报17.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452482546","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452482546?lang=zh_cn&edition=full","pubTime":"2024-07-18 21:31","pubTimestamp":1721309475,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日21时31分，4D Molecular Therapeutics, Inc.股票出现波动，股价大幅下挫5.00%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Onconetix, Inc.、Nkgen Biotech, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Onconetix, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为223.58%、123.31%、107.88%，振幅较大的相关个股有Onconetix, Inc.、亚狮康药业、Inventiva Sa，振幅分别为15.77%、11.27%、9.60%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182131159681e128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182131159681e128&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2450535501","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535501","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450535501?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:36","pubTimestamp":1720791417,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时36分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速上涨5.33%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。消息层面，截至21时36分，《富瑞集团维持4D Molecular Therapeutics买入评级，维持目标价58美元》资讯为影响4D Molecular Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213657af921ce1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213657af921ce1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2450363690","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450363690","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450363690?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:43","pubTimestamp":1720705435,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时43分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速上涨5.34%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。消息层面，截至21时43分，《Form 144 | 4D Molecular Therapeutics高管拟出售1.29万股股份，价值约29.99万美元》资讯为影响4D Molecular Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214356941f6458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214356941f6458&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2450073961","title":"4D Molecular Therapeutics, Inc.盘中异动 急速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450073961","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450073961?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:57","pubTimestamp":1720544275,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时57分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速上涨5.07%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃，换手率分别为10284.71%、2594.27%、334.84%，振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为327.50%、196.29%、134.00%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710005755aef8c0c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710005755aef8c0c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2446439299","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.14%报20.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446439299","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446439299?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:35","pubTimestamp":1719412553,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时35分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速跳水5.14%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。消息层面，截至22时35分，《加皇资本市场维持4D Molecular Therapeutics买入评级，维持目标价40美元》资讯为影响4D Molecular Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223554941f16bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223554941f16bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2446829184","title":"4D Molecular Therapeutics, Inc.盘中异动 快速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446829184","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446829184?lang=zh_cn&edition=full","pubTime":"2024-06-26 00:39","pubTimestamp":1719333577,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日00时39分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速跳水5.01%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.77%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。消息层面，截至00时39分，《Form 144 | 4D Molecular Therapeutics高管拟出售1.29万股股份，价值约30.06万美元》资讯为影响4D Molecular Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626003937941f0f94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626003937941f0f94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT","BK4139"],"gpt_icon":0},{"id":"2442540265","title":"4D Molecular Therapeutics, Inc.盘中异动 大幅拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442540265","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442540265?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199083,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速上涨5.20%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Avidity Biosciences, Inc.、Passage Bio, Inc.、Molecular Partners Ag涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为36.27%、18.90%、3.57%，振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Akari Therapeutics Plc，振幅分别为21.10%、20.93%、8.28%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213123941ee09d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213123941ee09d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0},{"id":"2441264717","title":"4D Molecular Therapeutics, Inc.盘中异动 急速下挫13.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441264717","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441264717?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:31","pubTimestamp":1717680718,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时31分，4D Molecular Therapeutics, Inc.股票出现波动，股价快速下挫13.05%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Virax Biolabs Group Limited、Vanda Pharmaceuticals Inc.、Viracta Therapeutics, Inc.涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1296.05%、73.27%、11.53%，振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028  Cl A、Virax Biolabs Group Limited、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为54.74%、22.41%、9.97%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406062131589f20cedb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406062131589f20cedb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2441147270","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441147270","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441147270?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:01","pubTimestamp":1717599676,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日23时01分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速拉升5.12%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Virios Therapeutics, Inc.、Kineta, Inc.、诺瓦瓦克斯医药涨幅较大，Cns Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、诺瓦瓦克斯医药较为活跃，换手率分别为58.21%、49.32%、12.47%，振幅较大的相关个股有Kineta, Inc.、Virios Therapeutics, Inc.、Biocardia Inc C/Wts 06/08/2024，振幅分别为63.28%、44.98%、41.80%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605230116aef391fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605230116aef391fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2440495449","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440495449","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440495449?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:41","pubTimestamp":1717422094,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时41分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速上涨5.38%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Bio-Path Holdings, Inc.、Biocardia Inc C/Wts 06/08/2024涨幅较大，Bio-Path Holdings, Inc.、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1847.10%、43.21%、22.90%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Kintara Therapeutics, Inc.，振幅分别为38.35%、24.17%、23.20%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060321413496811829&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060321413496811829&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FDMT"],"gpt_icon":0},{"id":"2437216952","title":"4D Molecular Therapeutics, Inc.盘中异动 快速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437216952","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437216952?lang=zh_cn&edition=full","pubTime":"2024-05-23 01:02","pubTimestamp":1716397349,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日01时02分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅上涨5.09%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Igm Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Gt Biopharma, Inc.较为活跃，换手率分别为331.89%、160.62%、47.56%，振幅较大的相关个股有Mustang Bio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Alpha Tau Medical Ltd C/Wts ，振幅分别为61.52%、57.14%、48.75%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052301023087e8918e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052301023087e8918e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2435519360","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519360","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435519360?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:33","pubTimestamp":1715693632,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时33分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅上涨5.01%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。该信息摘要如下：HC Wainwright & Co.：重申4D Molecular Therapeutics评级，由买入调整至买入评级, 目标价36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421335279279e78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421335279279e78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2435375379","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅上涨5.57%报27.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435375379","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435375379?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:52","pubTimestamp":1715608320,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时52分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速拉升5.57%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。该信息摘要如下：HC Wainwright & Co.：重申4D Molecular Therapeutics评级，由买入调整至买入评级, 目标价36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513215200861ecd0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513215200861ecd0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2435695325","title":"HC Wainwright & Co.：重申4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435695325","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435695325?lang=zh_cn&edition=full","pubTime":"2024-05-13 18:56","pubTimestamp":1715597769,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申4D Molecular Therapeutics(FDMT.US)评级，由买入调整至买入评级, 目标价36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131856118b011614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131856118b011614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FDMT"],"gpt_icon":0},{"id":"2434855383","title":"美国研究综述-Cerence、Epam Systems、Progyny","url":"https://stock-news.laohu8.com/highlight/detail?id=2434855383","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434855383?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:39","pubTimestamp":1715344798,"startTime":"0","endTime":"0","summary":"    路透5月10日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Cerence、Epam Systems 和 Progyny。要闻  * Cerence Inc   ：富国银行将其评级从 \"增持 \"下调至 \"等权重\"。* Epam Systems Inc   ：丰业银行将其评级从 \"跑赢大市 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFF","GAIN","BK4548","MTRN","GRWG","BK4227","BIGC","GFF","MKSI","CE","EPAM","ARWR","PGNY","ARHS","MRCY","APLT","BRT","GO","FDMT","LU0823414478.USD","LU2463526074.USD","LYFT","LU0053671581.USD","CPAY","CRNX","HLIO","BK4533","OBDC","LU1815336091.USD","LU0320765992.SGD","BK4539","ANIK","CMI","CRL","ACAD","FLNC","FOLD","NTLA","BK4109","HBI","MRC","BK4113","YOU","NTRA","MGNX","OXY","IE00B66KJ199.SGD","AVAH","EYE","FWRD"],"gpt_icon":0},{"id":"2433226444","title":"4D Molecular Therapeutics Inc   预计每股亏损74美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433226444","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433226444?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:10","pubTimestamp":1714997422,"startTime":"0","endTime":"0","summary":"   * 4D Molecular Therapeutics Inc    预计在5月8日公布截至2024年3月31日的业绩时，季度收入将出现增长(预计)    * 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于加利福尼亚州埃默里维尔的公司的营收预计将从一年前的29.8万美元增至78.5万美元，增幅为163.4%。* LSEG 分析师对 4D Molecular Therapeutics Inc 的平均预期是每股亏损 74 美分。* 华尔街对 4D Molecular Therapeutics Inc 的 12 个月目标价中位数为 45.00 美元，高于其最新收盘价 26.38 美元。5月6日 - 上一季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDMT","LENZ"],"gpt_icon":0},{"id":"2432977092","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅拉升5.53%报27.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432977092","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432977092?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:33","pubTimestamp":1714743214,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时33分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速上涨5.53%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Jaguar Health, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为69.18%、22.21%、11.11%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.、Relay Therapeutics, Inc.，振幅分别为15.86%、15.78%、13.56%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213335861ead45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213335861ead45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FDMT","LENZ","BK4139"],"gpt_icon":0},{"id":"2432835638","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘股价大涨5.06%报25.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432835638","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432835638?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:06","pubTimestamp":1714586811,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时06分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速上涨5.06%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Aptevo Therapeutics Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1401.54%、840.78%、249.77%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、84.43%、77.43%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050202065287e85358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050202065287e85358&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FDMT"],"gpt_icon":0},{"id":"2431628428","title":"4D Molecular Therapeutics, Inc.盘中异动 快速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431628428","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431628428?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:23","pubTimestamp":1714400632,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时23分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅上涨5.20%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Soleno Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为894.61%、35.93%、18.56%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Immunitybio, Inc.，振幅分别为33.33%、31.06%、29.01%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292223527924f388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292223527924f388&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FDMT","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.4dmoleculartherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.471},{"period":"1month","weight":-0.3679},{"period":"3month","weight":-0.4297},{"period":"6month","weight":-0.1544},{"period":"1year","weight":-0.2013},{"period":"ytd","weight":-0.2892}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"4D Molecular Therapeutics, Inc.于2015年3月11日根据特拉华州法律成立。该公司是一家临床阶段基因治疗公司，开创了利用其靶向和进化的AAV载体开发候选产品的先河。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.114674},{"month":2,"riseRate":0.25,"avgChangeRate":0.09912},{"month":3,"riseRate":0.75,"avgChangeRate":0.041874},{"month":4,"riseRate":0.25,"avgChangeRate":-0.130346},{"month":5,"riseRate":0.5,"avgChangeRate":-0.163827},{"month":6,"riseRate":0,"avgChangeRate":-0.078465},{"month":7,"riseRate":0.75,"avgChangeRate":0.01957},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.015275},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.104114},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.06274},{"month":11,"riseRate":0.666667,"avgChangeRate":0.644163},{"month":12,"riseRate":0.333333,"avgChangeRate":0.155196}],"exchange":"NASDAQ","name":"4D Molecular Therapeutics","nameEN":"4D Molecular Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"4D Molecular Therapeutics,FDMT,4D Molecular Therapeutics股票,4D Molecular Therapeutics股票老虎,4D Molecular Therapeutics股票老虎国际,4D Molecular Therapeutics行情,4D Molecular Therapeutics股票行情,4D Molecular Therapeutics股价,4D Molecular Therapeutics股市,4D Molecular Therapeutics股票价格,4D Molecular Therapeutics股票交易,4D Molecular Therapeutics股票购买,4D Molecular Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}